TB Fast Track patient cost data - User Guide

Persistent ID:

10.17037/DATA.00000815

Data Description

A tabular dataset containing information provided by 99 HIV-positive individuals – men and women aged 18 or above who had a low CD4 count and were not yet on TB or HIV treatment - enrolled in the TB FastTrack trial, a cluster randomised trial to establish the direct and indirect costs of illness incurred at the patient/household level. Data was collected through patient interviews conducted at the health facility where they were receiving treatment in North West Limpopo and Gauteng provinces between June 2014 and March 2015. The dataset contains 450+ variables, including details on quantity of visits, time spent in seeking care, direct medical and non-medical costs incurred, and individual and estimated household income. Household income was established using 4 approaches: (1) self-reported (detail), (2) self-reported (brackets), (3) by matching through an asset index, and (4) national average income.

Data Collection Methods

Interview: face-to-face

Data Analysis and Preparation

Data was collected and cleaned in Excel.  Analysis was conducted in Stata 14.

Geographic regions

North West Limpopo, and Gauteng provinces, South Africa

Key dates

Participants were interviewed between July 2014 and March 2015. Data cleaning and analysis took place between March 2016 and November 2017.

Quality Controls

The patient cost study was conducted alongside the TB FastTrack study, quality controls included a review of completed paper questionnaires by a health economist. Data entry errors and discrepancies were investigated by comparing conflicting entries against the paper questionnaires.

Species:

Human population

Ethics

The trial, including the costing study, was approved by the Research Ethics Committees of the University of Witwatersrand (approval number: R14/49 M111177), the London School of Hygiene and Tropical Medicine (approval number: 6099), and the Provincial Research Committees of Gauteng, North West and Limpopo.

Keywords

Tuberculosis, HIV, patient costs

Language of written material

English

Project title

TB FastTrack

Funder/Sponsor

The trial sponsor is the London School of Hygiene & Tropical Medicine.

The study was funded by Joint Global Health Trials (UK Medical Research Council, UK Department for International Development, Wellcome Trust). This UK-funded award is part of the EDCTP2 programme supported by the European Union. The patient cost analysis presented in this paper was supported by a grant from the Bill and Melinda Gates Foundation.

Grant Number

Project funding: Joint Global Health Trials number G1100689/1. Salary support: Bill and Melinda Gates Foundation grant number OPP1109722

Data Creators

Associated Roles

File Description